REBECCA GAYHEART: Open Payments
NPI 1417044215 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 8 companies in 2025. Trend: 2023 $357 · 2024 $211 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Novo Nordisk Inc | 1 | $32 |
| Lilly USA, LLC | 2 | $31 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: JARDIANCE, Wegovy, AIRSUPRA, PAXLOVID, PEDIARIX, INSPIRE, FARXIGA, EVENITY.
Industry payments across KY — which companies pay providers there.
